Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

NCT06046534 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06046534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 27, 2023
Completion date
June 10, 2024
Enrollment
46 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus